Parenteral acyclovir therapy for cytomegalovirus infection after renal transplantation
Nunan, T.O.; King, M.; Bull, P.; Banatvala, J.E.; Jones, N.F.; Hilton, P.J.
Clinical Nephrology 22(1): 28-31
1984
ISSN/ISBN: 0301-0430 PMID: 6090044 Document Number: 241146
Three patients who had received cadaveric renal transplants developed fevers within three months of transplantation. Concurrent cytomegalovirus infection was confirmed by virological studies. In all three patients there was both a clinical and virological response to a five day course of intravenous acyclovir. In one patient the dose required to produce this response was 5 mg/kg/day; however two patients required 10 mg/kg/day. All three patients remain well after 8-12 months follow-up.
Document emailed within 1 workday
Related Documents
Jirasiritham, S.; Sumethkul, V.; Chiewsilp, P.; Gojaseni, P. 1994: Prevention of recurrent herpes infection after renal transplantation by low-dose oral acyclovir Transplantation Proceedings 26(4): 2125-2126Waltzer, W.C.; Arnold, A.N.; Anaise, D.; Hurley, S.; Raisbeck, A.; Egelandsdsdal, B.; Pullis, C.; Rapaport, F.T. 1987: Impact of cytomegalovirus infection and HLA-matching on outcome of renal transplantation Transplantation Proceedings 19(5): 4077-4080
Fassbinder, W.; Bechstein, P.B.; Scheuermann, E.H.; Schoeppe, W. 1985: Incidence of cytomegalovirus-infection after renal transplantation and first experiences with prophylactic hyperimmunoglobulin Scandinavian Journal of Urology and Nephrology. Supplementum 92: 23-28
Terlizzi, M.E.; Costa, C.; Astegiano, S.; Sidoti, F.; Vendrame, R.; Segoloni, G.P.; Bergallo, M.; Cavallo, R. 2008: Monitoring of human Cytomegalovirus infection by antigenemia and viremia in the first 100 days following renal transplantation and relation to antiviral strategies Minerva Medica 99(3): 231-239
Steinmuller, D.R.; Graneto, D.; Swift, C.; Novick, A.C.; Streem, S.B.; Cunningham, R.J.; Hodge, E.; Bretan, P. 1989: Use of intravenous immunoglobulin prophylaxis for primary cytomegalovirus infection post living-related-donor renal transplantation Transplantation Proceedings 21(1 Pt 2): 2069-2071
Terlizzi, M.E.; Costa, C.; Astegiano, S.; Sidoti, F.; Vendrame, R.; Segoloni, G.P.; Bergallo, M.; Cavallo, R. 2008: Monitoring of human Cytomegalovirus infection by antigenemia and viremia in the first 100 days following renal transplantation and relation to antiviral strategies Minerva Medica 99(3): 231-239
Conti, D.J.; Freed, B.M.; Lempert, N. 1993: Prophylactic immunoglobulin therapy improves the outcome of renal transplantation in recipients at risk for primary cytomegalovirus disease Transplantation Proceedings 25(1 Part 2): 1421-1422
Shen, G.K.; Alfrey, E.J.; Knoppel, C.L.; Dafoe, D.C.; Scandling, J.D. 1997: Eradication of cytomegalovirus reactivation disease using high-dose acyclovir and targeted intravenous ganciclovir in kidney and kidney/pancreas transplantation Transplantation 64(6): 931-933
Cornella, C.; Torazza, M.C.; Strippoli, G.F.M.; Segoloni, G. 2007: Antiviral prophylaxis and pre-emptive therapy for the prevention of Cytomegalovirus infection in renal transplant recipients: guideline from the Italian Society of Nephrology Giornale Italiano di Nefrologia: Organo Ufficiale Della Societa Italiana di Nefrologia 24 Suppl. 37: S165-S178
Fabrizi, F.; Martin, P.; Elli, A.; Montagnino, G.; Banfi, G.; Passerini, P.; Campise, M.R.; Tarantino, A.; Ponticelli, C. 2007: Hepatitis C virus infection and rituximab therapy after renal transplantation International Journal of Artificial Organs 30(5): 445-449
Stuby, U.; Kaiser, W.; Grafinger, P.; Biesenbach, G.; Zazgornik, J. 1989: Urinary tract infection after renal transplantation under conventional therapy and cyclosporine Transplantation Proceedings 21(1 Pt 2): 2110-2111
Novitzky, N.; Jacobs, P. 1982: Acyclovir therapy in cutaneous herpes simplex following bone marrow transplantation. A case report South African Medical Journal 62(8): 251-252
Bernheim, J.; Touraine, J.L.; Berthoux, F.C.; Blanc, N.; Traeger, J. 1976: Rejections and cytomegalovirus infections after renal transplantation La Semaine des Hopitaux: Organe Fonde Par l'Association d'Enseignement Medical des Hopitaux de Paris 52(22-23): 1361-1365
Svedentsov, E.P.; Sharygin, S.L.; Epifanov, N.S.; Kuznetsova, N.I. 1994: Cytomegalovirus infection in bone marrow transplantation Gematologiia i Transfuziologiia 39(3): 30-33
Laske, A.; Carrel, T.; Niederhäuser, U.; Bauer, E.; Pasic, M.; von Segesser, L.K.; Gallino, A.; Turina, M. 1992: Prevention of cytomegalovirus infection following heart transplantation Helvetica Chirurgica Acta 58(4): 527-532
Laske, A.; Gallino, A.; Carrel, T.; Niederhäuser, U.; von Segesser, L.K.; Turina, M.I. 1993: Cytomegalovirus infection and prophylaxis in heart transplantation Transplantation Proceedings 25(1 Part 2): 1427-1428
Lloid, M.E.; Schubert, M.M.; Myerson, D.; Bowden, R.; Meyers, J.D.; Hackman, R.C. 1994: Cytomegalovirus infection of the tongue following marrow transplantation Bone Marrow Transplantation 14(1): 99-104
Ratnamohan, V.M.; Chapman, J.; Howse, H.; Bovington, K.; Robertson, P.; Byth, K.; Allen, R.; Cunningham, A.L. 1998: Cytomegalovirus and human herpesvirus 6 both cause viral disease after renal transplantation Transplantation 66(7): 877-882
Diosi, P.; Moldovan, E.; Rusinaru, D. 1982: Estimation of cytomegalovirus--imposed risks on the outcome of renal transplantation Archives Roumaines de Pathologie Experimentales et de Microbiologie 41(1): 35-41
Pouteil-Noble, C.; Bétuel, H.; Raffaele, P.; Megri, K.; Louvier, C.; Lefrançois, N.; Bosshard, S.; Dubernard, J.M.; Aymard, M.; Touraine, J.L. 1991: Influence of HLA compatibility on cytomegalovirus infection in kidney transplantation Presse Medicale 20(40): 2022-2024